Virtus Biotech Clinical Trials ETF (BBC) es una empresa que cotiza en bolsa en el Servicios Financieros sector, operando dentro de la Asset Management industria.
BBC tiene fecha de IPO 2014-12-17, cotiza en el NYSE, una capitalización de mercado de $36.78M.
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
